Memorandum Documents

Browse 17 memorandum documents from FDA and regulatory agencies.

17 documents available

5 shown

Recommendations for the Quarantine and Disposition of Units from Prior Collections from Donors with Repeatedly Reactive Screening Tests for Hepatitis B Virus (HBV), Hepatitis C Virus (HCV) and Human T-Lymphotropic Virus Type I (HTLV-I)

Memorandum

July 19, 1996

🏢Center for Biologics Evaluation and Research

biologics

Original Document

View Details

Additional Recommendations for Testing Whole Blood, Blood Components, Source Plasma and Source Leukocytes for Antibody to Hepatitis C Virus Encoded Antigen (Anti-HCV): Memorandum to Registered Blood and Plasma Establishments

Memorandum

May 16, 1996

🏢Center for Biologics Evaluation and Research

biologics

Original Document

View Details

Additional Recommendations for Donor Screening With a Licensed Test for HIV-1 Antigen: Memorandum to Registered Blood and Plasma Establishments

Memorandum

March 14, 1996

🏢Center for Biologics Evaluation and Research

biologics

Original Document

View Details

Donor Deferral Due to Red Blood Cell Loss During Collection of Source Plasma by Automated Plasmapheresis

Memorandum

December 4, 1995

🏢Center for Biologics Evaluation and Research

biologics

Original Document

View Details

Recommendations for Donor Screening with a Licensed Test for HIV-1 Antigen: Memorandum to All Registered Blood Establishments

Memorandum

August 8, 1995

🏢Center for Biologics Evaluation and Research

biologics

Original Document

View Details

Want to see more guidance documents?

Access all 17 memorandum documents with our comprehensive regulatory intelligence platform.

Document Statistics

Total Documents17

Document TypeMemorandum

Showing5 of 17

Quick Actions

Transform Regulatory Data into Actionable Intelligence

Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.

Try KeyPedia Today

Explore our real use cases and discover our features in depth.

Stay ahead of FDA enforcement

New KeyPedia insights, webinars, and regulatory analysis — straight to your inbox. Unsubscribe anytime.